PKD2L2 IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with PKD2L2 IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with PKD2L2 IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with PKD2L2 IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PKD2L2 IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 2210

Gene

crystallin beta B2 pseudogene 1

Gene

ribosomal protein L32 pseudogene 3

Gene

killer cell immunoglobulin like receptor, three Ig domains X1 (pseudogene)

Gene

HERC2 pseudogene 5

Gene

GUSB pseudogene 5

Gene

TMEM105 long non-coding RNA

Gene

SHOX homeobox

Gene

HERC2 pseudogene 8

Gene

CEA cell adhesion molecule 22, pseudogene

  • Gene

    long intergenic non-protein coding RNA 2210


  • Gene

    crystallin beta B2 pseudogene 1


  • Gene

    ribosomal protein L32 pseudogene 3


  • Gene

    killer cell immunoglobulin like receptor, three Ig domains X1 (pseudogene)


  • Gene

    HERC2 pseudogene 5


  • Gene

    GUSB pseudogene 5


  • Gene

    TMEM105 long non-coding RNA



  • Gene

    HERC2 pseudogene 8


  • Gene

    CEA cell adhesion molecule 22, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.